MSGID: 1:317/3 642cf97d
PID: hpt/lnx 1.9.0-cur 2019-01-08
TID: hpt/lnx 1.9.0-cur 2019-01-08
 Study to decode microbe-gut signaling suggests potential new treatment
for IBD 
 Harmful intestinal inflammation might be prevented with a one-two punch


  Date:
      April 4, 2023
  Source:
      Cincinnati Children's Hospital Medical Center
  Summary:
      Fresh insights into how our bodies interact with the microbes
      living in our guts suggest that a two-drug combination may offer
      a new way to treat inflammatory bowel diseases such as Crohn's
      disease and ulcerative colitis.


      Facebook Twitter Pinterest LinkedIN Email
FULL STORY
==========================================================================
Fresh insights into how our bodies interact with the microbes living
in our guts suggest that a two-drug combination may offer a new way to
treat inflammatory bowel diseases such as Crohn's disease and ulcerative
colitis.


==========================================================================
The potential treatment pathway emerges from a study led by experts at
Cincinnati Children's published online March 28, 2023, in the Journal of
Experimental Medicine. Co-first authors were Garrett Overcast, PhD, and
Hannah Meibers, BS. Corresponding author was Chandrashekhar Pasare, DVM,
PhD, Division of Immunobiology and co-director, Center for Inflammation
and Tolerance.

The research team conducted numerous experiments to learn about how
immune cells located in the lining of the intestine detect and respond to
microbes and relay important signals to gut epithelial cells. When the
signaling networks between immune cells and epithelial cells function
correctly, the immune system can live in harmony with friendly bacteria
residing in the gut.

Acting in unhealthy concert When microbe-to-cell signals get scrambled --
by genetic mutations or other causes such as damage to the intestinal
epithelium -- the immune system can either fail to react or can
over-react, which can lead to inflammatory bowel disease (IBD).

This study reveals that microbes are detected by cells of the immune
system located in the intestines. These immune cells deliver signals to
induce a protein called IL-1. This increases levels of another protein
called IL-22, which in turn, begins acting in concert with IL-1 to
activate the IL-1 receptor (IL-1R) expressed on intestinal epithelial
cells. Activation of IL-1R induces ROS gene activity in addition to other
genes that recruit inflammatory cells to the tissue. This chain reaction
drives an excessive inflammatory response that can damage the intestine,
the researchers say.

"The pathogenic role that IL-22 appears to play in inflammatory responses
- - due to its synergy with IL-1R signaling -- had not been made clear
previously," Pasare says. "We believe this may help explain why past
treatments for IBD that focused only on inhibiting IL-1? activity had
mixed results. We believe that a combined blockade of both IL-22 and
IL-1R could serve as a more promising treatment for IBD."  What's next?
Some monoclonal antibodies that can inhibit IL-22 or IL-1R have been
evaluated in clinical trials for various auto-immune conditions. The
research team is interested in exploring whether existing products can be
safely used in combination therapy or whether developing new treatments
that target the two pathways would be more effective.

Cincinnati Children's co-authors for this publication also included Emily
Eshleman, PhD, Irene Saha, PhD, Lisa Waggoner, MS, Krupaben Patel, BS,
David Haslam, MD, Theresa Alenghat, VMD, PhD, and Kelli VanDussen, PhD;
and Viral Jain, MD, University of Alabama at Birmingham.

    * RELATED_TOPICS
          o Health_&_Medicine
                # Immune_System # Colitis # Gastrointestinal_Problems
                # Lymphoma
          o Plants_&_Animals
                # Genetics # Molecular_Biology # Biology # Biotechnology
    * RELATED_TERMS
          o Microorganism o Irritable_bowel_syndrome o Pharmacology
          o Ketone_bodies o Coeliac_disease o Chemotherapy o
          Personalized_medicine o Prion

==========================================================================
Story Source: Materials provided by
Cincinnati_Children's_Hospital_Medical_Center. Note: Content may be
edited for style and length.


==========================================================================
Journal Reference:
   1. Garrett R. Overcast, Hannah E. Meibers, Emily M. Eshleman,
   Irene Saha,
      Lisa Waggoner, Krupaben N. Patel, Viral G. Jain, David
      B. Haslam, Theresa Alenghat, Kelli L. VanDussen, Chandrashekhar
      Pasare. IEC-intrinsic IL-1R signaling holds dual roles in regulating
      intestinal homeostasis and inflammation. Journal of Experimental
      Medicine, 2023; 220 (6) DOI: 10.1084/jem.20212523
==========================================================================

Link to news story:
https://www.sciencedaily.com/releases/2023/04/230404114152.htm

--- up 1 year, 5 weeks, 1 day, 10 hours, 50 minutes
 * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)
SEEN-BY: 15/0 106/201 114/705 123/120 153/7715 226/30 227/114 229/110
SEEN-BY: 229/111 112 113 307 317 400 426 428 470 664 700 292/854 298/25
SEEN-BY: 305/3 317/3 320/219 396/45
PATH: 317/3 229/426